Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 5
2016 2
2017 5
2018 11
2019 8
2020 9
2021 5
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.
Dutta AK, Jain A, Jearth V, Mahajan R, Panigrahi MK, Sharma V, Goenka MK, Kochhar R, Makharia G, Reddy DN, Kirubakaran R, Ahuja V, Berry N, Bhat N, Dutta U, Ghoshal UC, Jain A, Jalihal U, Jayanthi V, Kumar A, Nijhawan S, Poddar U, Ramesh GN, Singh SP, Zargar S, Bhatia S. Dutta AK, et al. Among authors: kirubakaran r. Indian J Gastroenterol. 2023 Oct;42(5):601-628. doi: 10.1007/s12664-023-01428-7. Epub 2023 Sep 12. Indian J Gastroenterol. 2023. PMID: 37698821 Review.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ, Storm MRO, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, Schaug JP, Darling Rasmussen P, Huus CL, Zwi M, Kirubakaran R, Simonsen E, Gluud C. Storebø OJ, et al. Among authors: kirubakaran r. Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article. Review.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C. Storebø OJ, et al. Among authors: kirubakaran r. Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. PMID: 26599576 Free PMC article. Updated. Review.
Virtual reality distraction for acute pain in children.
Lambert V, Boylan P, Boran L, Hicks P, Kirubakaran R, Devane D, Matthews A. Lambert V, et al. Among authors: kirubakaran r. Cochrane Database Syst Rev. 2020 Oct 22;10(10):CD010686. doi: 10.1002/14651858.CD010686.pub2. Cochrane Database Syst Rev. 2020. PMID: 33089901 Free PMC article.
Favipiravir for treating COVID-19.
Korula P, Alexander H, John JS, Kirubakaran R, Singh B, Tharyan P, Rupali P. Korula P, et al. Among authors: kirubakaran r. Cochrane Database Syst Rev. 2024 Feb 5;2(2):CD015219. doi: 10.1002/14651858.CD015219.pub2. Cochrane Database Syst Rev. 2024. PMID: 38314855 Free PMC article. Review.
Botulinum toxin for motor and phonic tics in Tourette's syndrome.
Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD. Pandey S, et al. Among authors: kirubakaran r. Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012285. doi: 10.1002/14651858.CD012285.pub2. Cochrane Database Syst Rev. 2018. PMID: 29304272 Free PMC article. Review.
69 results